Logo

pharmacogenetics

Genomadix Gets FDA 510(k) Clearance for PCR System, CYP2C19 Test

Canada's Genomadix, formerly known as Spartan Bioscience, expects to now commercialize the system and test in the US to guide therapy decisions.

University of Florida College of Pharmacy Kicks Off Consumer-Facing PGx Education Service
Premium

Patients in Florida and New Jersey can request a $199 video consultation with a pharmacist to interpret pharmacogenetic test results from approved labs.

PGx Testing Reduces Adverse Drug Events, Multi-Site European Study Finds
Premium

The three-year Ubiquitous Pharmacogenomics Consortium's PREPARE study enrolled nearly 7,000 patients in seven European countries.

UCSF Health Set to Launch Clinical Pharmacogenetics Program
Premium

Doctors will be able to test patients for 17 genes known to influence response to 62 drugs and receive guidance from EHR-embedded pre- and post-test alerts.

Proove Biosciences CEO Exonerated in PGx Test Kickback Case

Proove's founder and CEO was indicted last year on charges the company had defrauded Medicare and violated the Anti-Kickback Statute by paying physicians to use its pharmacogenetic tests.

Dec 19, 2022

FDA Updates Xeloda Labeling to Make DPYD Variant Risks More Explicit

Dec 13, 2022

NIH All of Us Program Returns First Health-Related Genetic Results to Participants
Premium

Dec 2, 2022

UChicago Testing Pharmacogenomics for Surgical Patients in Clinical Trial
Premium

Nov 18, 2022

Avera Health Publishes Clinical Validation of PGx Panel for Depression Treatment Optimization
Premium

Oct 27, 2022

23andMe Gains FDA Clearance for Simvastatin Pharmacogenetic Report

Oct 19, 2022

Genetika+ Snags CE Mark for Major Depressive Disorder Drug-Matching Test

Oct 17, 2022

LetsGetChecked Eyeing Payors, Employers as Customers for New PGx Service
Premium

Oct 11, 2022

Genetika+ Combines PGx, 'Brain-in-a-Dish' Model to Personalize Depression Meds
Premium

Aug 26, 2022

AMP Publishes Recommendations for TPMT, NUDT15 Genotyping Assay Standardization

Aug 18, 2022

Cancer Centers Nudge Oncologists Toward DPYD Testing as PGx Supporters Push For Guidelines Change
Premium

Apr 13, 2022

Mayo Clinic Study Bolsters Implementation of PGx Data in Clinical Practice
Premium

Apr 7, 2022

UK Study Supports Clinical Adoption of Genedrive Newborn Hearing Loss Test Within NHS
Premium

Mar 29, 2022

UK Report Urges Widespread NHS Uptake of Pharmacogenomics

Feb 28, 2022

Legislators Introduce Bill Seeking to Raise PGx Awareness, Adoption
Premium

Nov 10, 2021

23andMe Fiscal Q2 Revenues Increase 7 Percent

Jul 21, 2021

Ochsner Health Integrating ActX Genomic Decision Support to Pilot Cancer PGx Project

Jun 10, 2021

AMP-led Expert Groups Release Clinical CYP2D6 Pharmacogenomic Testing Recommendation

May 26, 2021

23andMe Begins Reporting PGx Variants With Drug Info Under Recent FDA Clearance
Premium

Jan 26, 2021

Genomind Receives Medicare Coverage for Pharmacogenetics Test

Dec 3, 2020

Pharmacogenetic Testing for Statin Side Effects Doesn't Result in Worse Blood Cholesterol Levels

Breaking News
The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.